Christopher Moxham - 10 Aug 2021 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Scientific Officer
Signature
/s/ Peter Thomson, as attorney-in-fact for Christopher Moxham
Issuer symbol
FULC
Transactions as of
10 Aug 2021
Net transactions value
-$505,422
Form type
4
Filing time
12 Aug 2021, 16:20:57 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FULC Common Stock Options Exercise $162,398 +20,714 $7.84 20,714 10 Aug 2021 Direct F1
transaction FULC Common Stock Sale $352,138 -20,714 -100% $17.00 0 10 Aug 2021 Direct F1
transaction FULC Common Stock Options Exercise $243,597 +31,071 $7.84 31,071 10 Aug 2021 Direct F2
transaction FULC Common Stockm Sale $559,278 -31,071 -100% $18.00 0 10 Aug 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Options Exercise $0 -20,714 -17% $0.000000 103,572 10 Aug 2021 Common Stock 20,714 $7.84 Direct F1, F3
transaction FULC Stock Option (right to buy) Options Exercise $0 -31,071 -30% $0.000000 72,501 10 Aug 2021 Common Stock 31,071 $7.84 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2020.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2021.
F3 The shares underlying the option are scheduled to vest 25% on the first anniversary of the vesting commencement date of January 22, 2020. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.